Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
92.93
(
1.72%
)
Bitcoin
73,792.78
(
0.32%
)
News Focus
News Focus
Post# of 130524
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

SpecTrader

Send PM Follow Ignore
Followers 208
Posts 12050
Boards Moderated 3
Alias Born 08/03/2009

SpecTrader

Re: Forty Six & 2 post# 54221

Monday, 02/04/2013 1:13:23 PM

Monday, February 04, 2013 1:13:23 PM

Post# of 130524
NuroPro Diagnostic Blood Test Platform
Amarantus Bioscience, Inc. acquired the IP behind the NuroPro test for Parkinson’s and several other indications in December 2012. A full list of indications covered is below:

Parkinson’s disease
Alzheimer’s disease
Lou Gehrig’s disease (ALS)
Neuromuscular disease
Breast Cancer
Chonic Myelogenous Leukemia

~AMBS
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote